Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$13.31 - $19.41 $14.1 Million - $20.5 Million
-1,055,735 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$13.06 - $21.24 $4.87 Million - $7.91 Million
-372,563 Reduced 26.08%
1,055,735 $15.2 Million
Q4 2019

Feb 10, 2020

BUY
$17.29 - $21.74 $2.49 Million - $3.13 Million
144,189 Added 11.23%
1,428,298 $29.1 Million
Q3 2019

Nov 12, 2019

BUY
$19.51 - $24.28 $1.79 Million - $2.23 Million
91,701 Added 7.69%
1,284,109 $25.1 Million
Q2 2019

Aug 06, 2019

BUY
$21.47 - $37.33 $1.26 Million - $2.2 Million
58,842 Added 5.19%
1,192,408 $26.9 Million
Q1 2019

May 07, 2019

SELL
$28.4 - $36.49 $2.64 Million - $3.4 Million
-93,077 Reduced 7.59%
1,133,566 $41.4 Million
Q4 2018

Feb 06, 2019

BUY
$27.94 - $44.61 $1.32 Million - $2.1 Million
47,151 Added 4.0%
1,226,643 $36.2 Million
Q3 2018

Nov 02, 2018

BUY
$38.6 - $46.12 $826,233 - $987,198
21,405 Added 1.85%
1,179,492 $50.1 Million
Q2 2018

Aug 14, 2018

SELL
$40.56 - $51.36 $79.8 Million - $101 Million
-1,967,654 Reduced 62.95%
1,158,087 $47.7 Million
Q1 2018

May 07, 2018

SELL
$53.61 - $67.26 $8.96 Million - $11.2 Million
-167,209 Reduced 5.08%
3,125,741 $181 Million
Q4 2017

Feb 14, 2018

BUY
$47.69 - $55.39 $24.5 Million - $28.4 Million
513,586 Added 18.48%
3,292,950 $180 Million
Q3 2017

Nov 13, 2017

BUY
$49.16 - $54.45 $38.9 Million - $43.1 Million
790,692 Added 39.76%
2,779,364 $141 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,988,672
1,988,672 $115 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Thornburg Investment Management Inc Portfolio

Follow Thornburg Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.